Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Daltonics to Manufacture Ibis' Biosensor System

NEW YORK (GenomeWeb News) — Bruker Daltonics has signed an agreement to become the exclusive worldwide manufacturer of Ibis Bioscience’s T5000 universal biosensor system, the companies said today.
 
Ibis, a subsidiary of Isis Pharmaceuticals, developed the system for the identification of thousands of types of infectious organisms in a sample. The system incorporates Bruker Daltonics' micrOTOF ESI-TOF mass spectrometer.
 
According to the companies, Bruker Daltonics will also handle order processing, system installations, and service in North America, Europe, and the Middle East. In Europe and the Middle East, Bruker Daltonics will have exclusive rights to sell the systems and Ibis infectious organism identification kits for various government applications, as well as non-exclusive rights to sell to all other customers for all other applications except diagnostics.
 
Outside of Bruker Daltonics’ exclusive market, Isis may see the T5000 systems and Ibis’ infectious organism identification kits.
 
Additional terms of the arrangement were not disclosed.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.